Minovia doses patient in first mitochondrial cell therapy trial for the treatment of Pearson syndrome
— Compassionate use results to be presented at UMDF’s Mitochondrial Medicine 2019 symposium — — Minovia initiates U.S. operations in…
Pharmaceuticals, Biotechnology and Life Sciences
— Compassionate use results to be presented at UMDF’s Mitochondrial Medicine 2019 symposium — — Minovia initiates U.S. operations in…
DUBLIN–(BUSINESS WIRE)–The “Pyrogen Testing Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…
Bioasis submitted to the FDA its pre-IND briefing document in support of the xB3-001 program for the treatment of patients with confirmed human epidermal growth factor receptor 2 (“HER2”)-positive (“HER2+”) breast cancer and brain metastases.
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF): To our shareholders, As we approach the end of Phase 2 development…
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2019 financial results after…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific over the Counter (OTC) Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been…
WESTON, Fla.–(BUSINESS WIRE)–ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most advanced next generation pertussis vaccine,…
The new partnership will help change the landscape of life science boardrooms by expanding executive women’s resources and visibility NEW…
DUBLIN–(BUSINESS WIRE)–The “Companion Diagnostics Market (2nd Edition), 2019-2030” report has been added to ResearchAndMarkets.com’s offering. The Companion Diagnostics Market (2nd…